Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3928693
Max Phase: Preclinical
Molecular Formula: C33H51N7O16
Molecular Weight: 801.80
Molecule Type: Protein
Associated Items:
ID: ALA3928693
Max Phase: Preclinical
Molecular Formula: C33H51N7O16
Molecular Weight: 801.80
Molecule Type: Protein
Associated Items:
Canonical SMILES: CC(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
Standard InChI: InChI=1S/C33H51N7O16/c1-15(2)12-21(33(55)56)38-28(50)18(7-9-24(44)45)36-23(43)14-34-31(53)27(16(3)41)39-29(51)19(8-10-25(46)47)37-30(52)22-6-5-11-40(22)32(54)20(13-26(48)49)35-17(4)42/h15-16,18-22,27,41H,5-14H2,1-4H3,(H,34,53)(H,35,42)(H,36,43)(H,37,52)(H,38,50)(H,39,51)(H,44,45)(H,46,47)(H,48,49)(H,55,56)/t16-,18+,19+,20+,21+,22+,27+/m1/s1
Standard InChI Key: JNGVVGXJVLYMRP-UBCURMOZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 801.80 | Molecular Weight (Monoisotopic): 801.3392 | AlogP: -3.75 | #Rotatable Bonds: 24 |
Polar Surface Area: 364.34 | Molecular Species: ACID | HBA: 12 | HBD: 11 |
#RO5 Violations: 3 | HBA (Lipinski): 23 | HBD (Lipinski): 11 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.32 | CX Basic pKa: | CX LogP: -5.00 | CX LogD: -17.71 |
Aromatic Rings: 0 | Heavy Atoms: 56 | QED Weighted: 0.04 | Np Likeness Score: 0.00 |
1. Jiang ZY, Lu MC, You QD.. (2016) Discovery and Development of Kelch-like ECH-Associated Protein 1. Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction Inhibitors: Achievements, Challenges, and Future Directions., 59 (24): [PMID:27690435] [10.1021/acs.jmedchem.6b00586] |
2. Li Q, Xing S, Chen Y, Liao Q, Li Q, Liu Y, He S, Feng F, Chen Y, Zhang J, Liu W, Guo Q, Sun Y, Sun H.. (2020) Reasonably activating Nrf2: A long-term, effective and controllable strategy for neurodegenerative diseases., 185 [PMID:31735576] [10.1016/j.ejmech.2019.111862] |
3. Mou Y, Wen S, Li YX, Gao XX, Zhang X, Jiang ZY.. (2020) Recent progress in Keap1-Nrf2 protein-protein interaction inhibitors., 202 [PMID:32668381] [10.1016/j.ejmech.2020.112532] |
Source(1):